
Ubigene has established a comprehensive KO cell line bank of over 10,000 knockout (KO) cell lines, targeting thousands of genes across eight major signaling pathways, key immune checkpoint regulators, and a wide range of disease models, primarily in oncology. Our portfolio continues to expand. All KO cell lines are rigorously validated by PCR and Sanger sequencing. For each product, Ubigene provides detailed cell use instructions (including validation data), a mycoplasma testing report (covering 75 common species), and an STR authentication report. We ensure that all KO cell lines are mycoplasma-free and exhibit high viability. In addition, Ubigene offers complimentary technical support to facilitate your research. KO cell lines are available starting at $990, with a rapid delivery timeline of approximately one week. If the targeted KO cell line is not available in our current cell line bank, Ubigene also offers customized KO cell line services. Please contact us for further technical assistance.
